Highlights
NASDAQ: GLMD       Galmed Pharmaceutica
Last Price Today's Change   Day's Range   Trading Volume
6.50   -0.11 (1.66%)  5.80 - 6.79  220,100

Overview

 
Avg Volume (4 weeks):155,975
4 Weeks Range:4.10 - 7.38
4 Weeks Price Volatility (%):
73.17%
52 Weeks Range:3.418 - 9.74
52 Weeks Price Volatility (%):
48.75%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers